Alvotech (ALVO)
Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami
Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
Positive Interim 2-Year Data from enVVeno Medicals VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
Positive Interim 2-Year Data from enVVeno Medical’s VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting
Talkspace to Participate in Upcoming Investor Conferences
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock
Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors